Evidence map›Paper›PMID 32736929›Full record

ArticleEuropean urology2020

Re-establishing the Role of Robot-assisted Radical Cystectomy After the 2020 EAU Muscle-invasive and Metastatic Bladder Cancer Guideline Panel Recommendations.

Francesco Montorsi, Marco Bandini, Alberto Briganti, Prokar Dasgupta, Andrea Gallina, Michele Gallucci, Inderbir S Gill, Khurshid A Guru, Ashok Hemal, Mani Menon and 12 more

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in European urology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Open vs Robotic Surgery.Bladder cancer (Amsterdam, Netherlands) · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 16 institutions in 10 countries.

Francesco MontorsiDivision of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: montorsi.francesco@hsr.it.
Marco BandiniDivision of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Alberto BrigantiDivision of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Prokar DasguptaMRC Centre for Transplantation, King's College London, Department of Urology, Guy's Hospital, London, UK.
Andrea GallinaDivision of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy.
Michele GallucciDepartment of Urology, Sapienza University, Rome, Italy.
Inderbir S GillDepartment of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Khurshid A GuruDepartment of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
Ashok HemalDepartment of Urology, Wake Forest University Baptist Medical Center, Winston-Salem, NC, USA.
Mani MenonHenry Ford Health System, Detroit, MI, USA.
Marco MoschiniDivision of Oncology/Unit of Urology, Urological Research Institute, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland.
Declan G MurphyDivision of Cancer Surgery, Peter MacCallum Cancer Centre, East Melbourne, Australia.
Dipen J ParekhDepartment of Urology, University of Miami Miller School of Medicine, Miami, FL, USA.
Hiten D PatelThe James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Hiten R H PatelDepartment of Urology, University Hospital of Northern Norway, Tromsø, Norway.
Michael StöckleUniversity of the Saarland, Homburg Saar, Germany.
Ash K TewariDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Carl J WijburgRijnstate Hospital, Arnhem, The Netherlands.
Peter WiklundDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Molecular Medicine and Surgery, Section of Urology, Karolinska Institutet, Stockholm, Sweden.
Timothy G WilsonJohn Wayne Cancer Institute, Santa Monica, CA, USA.
Alexandre MottrieDepartment of Urology, Onze Lieve Vrouw Hospital, Aalst, Belgium; ORSI Academy, Melle, Belgium.
EAU Robotic Urology Section Scientific Working Group
Vita-Salute San Raffaele University · ITUniversity Hospital of North Norway · NOAtrium Health Wake Forest Baptist · USGuy's Hospital · GBHenry Ford Health System · USIcahn School of Medicine at Mount Sinai · USKarolinska Institutet · SEORSI Academy · BEPeter MacCallum Cancer Centre · AURijnstate Hospital · NLRoswell Park Comprehensive Cancer Center · USSaarland University · DESaint John's Health Center · USSapienza University of Rome · ITUniversity of Miami · USUniversity of Southern California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The EAU guidelines panel on muscle-invasive and metastatic bladder cancer (MIBC) recently recommended open radical cystectomy (ORC) as the best surgical approach for MIBC patients. We critically re-examine the indications for considering ORC as the first choice over robot-assisted radical cystectomy. To the best of our knowledge, this is not supported by trials or meta-analyses.

Indexed as

RoboticsRobotic Surgical ProceduresUrinary Bladder NeoplasmsUrologyCystectomyHumansMusclesPractice Guidelines as Topic

Identifiers

PMID32736929
OpenAlexW3046148859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.